Alkeon Capital Management LLC Raises Stock Holdings in Lam Research Corporation $LRCX

Alkeon Capital Management LLC grew its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 6.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,504,456 shares of the semiconductor company’s stock after acquiring an additional 550,000 shares during the quarter. Lam Research comprises approximately 1.4% of Alkeon Capital Management LLC’s holdings, making the stock its 11th largest holding. Alkeon Capital Management LLC owned 0.67% of Lam Research worth $827,824,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Bahl & Gaynor Inc. raised its stake in Lam Research by 1.9% during the second quarter. Bahl & Gaynor Inc. now owns 5,602 shares of the semiconductor company’s stock valued at $545,000 after purchasing an additional 102 shares in the last quarter. BankPlus Wealth Management LLC increased its holdings in shares of Lam Research by 2.0% in the 2nd quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock worth $511,000 after buying an additional 105 shares during the last quarter. ORG Partners LLC increased its holdings in shares of Lam Research by 7.3% in the 2nd quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock worth $162,000 after buying an additional 114 shares during the last quarter. Quotient Wealth Partners LLC raised its position in shares of Lam Research by 2.1% during the 2nd quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock valued at $529,000 after buying an additional 114 shares in the last quarter. Finally, Fairvoy Private Wealth LLC lifted its holdings in shares of Lam Research by 3.0% in the 2nd quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after acquiring an additional 120 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on LRCX. The Goldman Sachs Group boosted their price objective on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, October 8th. Hsbc Global Res upgraded Lam Research to a “hold” rating in a report on Tuesday, September 30th. Cantor Fitzgerald restated an “overweight” rating and set a $170.00 price target on shares of Lam Research in a report on Thursday, October 23rd. Berenberg Bank raised their price target on Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Evercore ISI lifted their price objective on shares of Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and an average price target of $152.87.

Lam Research Stock Performance

LRCX stock opened at $160.52 on Friday. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $169.69. The firm has a market cap of $201.62 billion, a price-to-earnings ratio of 35.36, a PEG ratio of 1.73 and a beta of 1.77. The business’s fifty day simple moving average is $152.53 and its two-hundred day simple moving average is $119.99. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is currently 22.91%.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the transaction, the insider owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is owned by insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.